• References

    American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism.
    Endocrine Practice. 2002;8:457-469.

    Hyperthyroidism. EBSCO DynaMed website. Available at: Updated March 12, 2013. Accessed November 25, 2013.

    Shomon M. Frequently asked questions on Graves' disease & hyperthyroidism. Thyroid-Info website. Available at: Updated November 25, 2013. Accessed November 25, 2013.

    Van Geest RJ, Sa sim IV, Koppeschaar HP, et al. Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study.
    Eur J Endocrinol.

    1/30/2009 DynaMed's Systematic Literature Surveillance Nyirenda MJ, Taylor PN, Stoddart M, Beckett GJ, Toft AD. Thyroid-stimulating hormone-receptor antibody and thyroid hormone concentrations in smokers vs nonsmokers with Graves disease treated with carbimazole.

    7/6/2009 DynaMed's Systematic Literature Surveillance Safety: propylthiouracil. US Food and Drug Administration website. Available at: Updated April 21, 2010. Accessed November 25, 2013.

    6/10/2014 DynaMed's Systematic Literature Surveillance Alhefdhi A, Mazeh H, et al. Role of postoperative vitamin D and/or calcium routine supplementation in preventing hypocalcemia after thyroidectomy: a systematic review and meta-analysis. Oncologist. 2013;18(5):553-542.

  • Resources

    American Thyroid Association

    National Graves' Disease Foundation

  • Canadian Resources

    Thyroid Foundation of Canada